Pfizer, Starboard Value
(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...
Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...
Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.
Activist investor Starboard Value has taken a sizeable stake in Kenvue, the maker of Tylenol and Listerine, and is seeking ...
Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's board needs to hold ...
Tylenol, Listerine and Band-Aid maker Kenvue is the latest in the health-related sector to attract an activist investor. And not just any corporate agitator, Starboard Value, which in recent days ...
Starboard Value criticizes Pfizer's leadership for underperformance, citing a 50% stock decline and missed growth targets ...
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
The activist investor claims Pfizer failed to capitalize on the windfall earned from its COVID-19 vaccine and, in the process, destroyed tens of billions of dollars in market value.
Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...
Hedge fund Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback